Pregled bibliografske jedinice broj: 1098330
An international perspective on hospitalized patients with viral community-acquired pneumonia
An international perspective on hospitalized patients with viral community-acquired pneumonia // European Journal of Internal Medicine, 60 (2019), 54-70 doi:10.1016/j.ejim.2018.10.020 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1098330 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
An international perspective on hospitalized
patients with viral community-acquired pneumonia
Autori
Radovanović, Dejan ; Sotgiu, Giovanni ; Janković, Mateja ; Mahesh, Padukudru Anand ; Marcos, Pedro Jorge ; Abdalla, Mohamed I. ; et. al
Kolaboracija
GLIMP Study Group
Izvornik
European Journal of Internal Medicine (0953-6205) 60
(2019);
54-70
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Community acquired pneumonia ; Influenza ; Oseltamivir ; Testing ; Viral pneumonia ; Viral swab
Sažetak
Background: Who should be tested for viruses in patients with community acquired pneumonia (CAP), prevalence and risk factors for viral CAP are still debated. We evaluated the frequency of viral testing, virus prevalence, risk factors and treatment coverage with oseltamivir in patients admitted for CAP. Methods: Secondary analysis of GLIMP, an international, multicenter, point- prevalence study of hospitalized adults with CAP. Testing frequency, prevalence of viral CAP and treatment with oseltamivir were assessed among patients who underwent a viral swab. Univariate and multivariate analysis was used to evaluate risk factors. Results: 553 (14.9%) patients with CAP underwent nasal swab. Viral CAP was diagnosed in 157 (28.4%) patients. Influenza virus was isolated in 80.9% of cases. Testing frequency and viral CAP prevalence were inhomogeneous across the participating centers. Obesity (OR 1.59, 95%CI: 1.01-2.48 ; p = 0.043) and need for invasive mechanical ventilation (OR 1.62, 95%CI: 1.02-2.56 ; p = 0.040) were independently associated with viral CAP. Prevalence of empirical treatment with oseltamivir was 5.1%. Conclusion: In an international scenario, testing frequency for viruses in CAP is very low. The most common cause of viral CAP is Influenza virus. Obesity and need for invasive ventilation represent independent risk factors for viral CAP. Adherence to recommendations for treatment with oseltamivir is poor
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinika za plućne bolesti "Jordanovac",
Klinički bolnički centar Zagreb
Profili:
Mateja Janković Makek
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE